Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination
Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved..
RATIONALE AND OBJECTIVES: Vaccine-related lymphadenopathy is a frequent finding following initial coronavirus disease 2019 (COVID-19) vaccination, but the frequency after COVID-19 booster vaccination is still unknown. In this study we compare axillary lymph node morphology on breast MRI before and after COVID-19 booster vaccination.
MATERIALS AND METHODS: This retrospective, single-center, IRB-approved study included patients who underwent breast MRI between October 2021 and December 2021 after the COVID-19 booster vaccination. The axillary lymph node with the greatest cortical thickness ipsilateral to the side of vaccination was measured on MRI after booster vaccination and before initial COVID-19 vaccination. Comparisons were made between patients with and without increase in cortical thickness of ≥ 0.2 cm. Continuous covariates were compared using Wilcoxon rank-sum test and categorical covariates were compared using Fisher's exact test. Multiple comparison adjustment was made using the Benjamini-Hochberg procedure.
RESULTS: All 128 patients were included. Twenty-four of 128 (19%) displayed an increase in lymph node cortical thickness of ≥ 0.2 cm. Patients who received the booster more recently were more likely to present cortical thickening, with a median of 9 days (IQR 5, 20) vs. 36 days (IQR 18, 59) (p < 0.001). Age (p = 0.5) and type of vaccine (p = 0.7) were not associated with thickening. No ipsilateral breast cancer or malignant lymphadenopathy were diagnosed on follow-up.
CONCLUSION: Axillary lymphadenopathy on breast MRI following COVID-19 booster vaccination is a frequent finding, especially in the first 3 weeks after vaccination. Additional evaluation or follow-up may be omitted in patients with low concern for malignancy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Academic radiology - 31(2024), 3 vom: 23. März, Seite 755-760 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Parikh, Rooshi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breast neoplasms |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.acra.2023.03.012 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355422352 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM355422352 | ||
003 | DE-627 | ||
005 | 20240326234807.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.acra.2023.03.012 |2 doi | |
028 | 5 | 2 | |a pubmed24n1348.xml |
035 | |a (DE-627)NLM355422352 | ||
035 | |a (NLM)37037711 | ||
035 | |a (PII)S1076-6332(23)00124-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Parikh, Rooshi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved. | ||
520 | |a RATIONALE AND OBJECTIVES: Vaccine-related lymphadenopathy is a frequent finding following initial coronavirus disease 2019 (COVID-19) vaccination, but the frequency after COVID-19 booster vaccination is still unknown. In this study we compare axillary lymph node morphology on breast MRI before and after COVID-19 booster vaccination | ||
520 | |a MATERIALS AND METHODS: This retrospective, single-center, IRB-approved study included patients who underwent breast MRI between October 2021 and December 2021 after the COVID-19 booster vaccination. The axillary lymph node with the greatest cortical thickness ipsilateral to the side of vaccination was measured on MRI after booster vaccination and before initial COVID-19 vaccination. Comparisons were made between patients with and without increase in cortical thickness of ≥ 0.2 cm. Continuous covariates were compared using Wilcoxon rank-sum test and categorical covariates were compared using Fisher's exact test. Multiple comparison adjustment was made using the Benjamini-Hochberg procedure | ||
520 | |a RESULTS: All 128 patients were included. Twenty-four of 128 (19%) displayed an increase in lymph node cortical thickness of ≥ 0.2 cm. Patients who received the booster more recently were more likely to present cortical thickening, with a median of 9 days (IQR 5, 20) vs. 36 days (IQR 18, 59) (p < 0.001). Age (p = 0.5) and type of vaccine (p = 0.7) were not associated with thickening. No ipsilateral breast cancer or malignant lymphadenopathy were diagnosed on follow-up | ||
520 | |a CONCLUSION: Axillary lymphadenopathy on breast MRI following COVID-19 booster vaccination is a frequent finding, especially in the first 3 weeks after vaccination. Additional evaluation or follow-up may be omitted in patients with low concern for malignancy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Breast neoplasms | |
650 | 4 | |a Lymphadenopathy | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Pandemic | |
650 | 4 | |a Vaccines | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Feigin, Kimberly N |e verfasserin |4 aut | |
700 | 1 | |a Sevilimedu, Varadan |e verfasserin |4 aut | |
700 | 1 | |a Huayanay, Jorge |e verfasserin |4 aut | |
700 | 1 | |a Pinker, Katja |e verfasserin |4 aut | |
700 | 1 | |a Horvat, Joao V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Academic radiology |d 1995 |g 31(2024), 3 vom: 23. März, Seite 755-760 |w (DE-627)NLM087676818 |x 1878-4046 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2024 |g number:3 |g day:23 |g month:03 |g pages:755-760 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.acra.2023.03.012 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2024 |e 3 |b 23 |c 03 |h 755-760 |